Screener
Eligibility screening
Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms an…
Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStudy detailsClinicalTrials.gov
1 US site in MD
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.